Cytokinetics | CYTK - 市值



金融业
股票价格
USD
资产
USD 1.27B
现金及等价物
USD 129.84M
销售成本
USD 160K
流动资产
USD 839.47M
流动负债
USD 199.19M
债务
USD 1.29B
EBIT
USD -181.23M
EBITDA
USD -169.32M
员工
498
EPS每股收益
USD -1.67
股本和储备
USD -826.57M
销售毛利
USD 19.2M
债务利息支出
USD 33.34M
利息收入
USD 11.02M
贷款资金
USD 247.21M
市值
USD 8.82B
净收入
USD -206.03M
营业费用
USD 200.58M
营业利润
USD -181.23M
普通股股本
USD 124.43M
税前利润
USD -206.03M
销售收入
USD 19.35M
销售和管理费用
USD 104.9M
股票
USD 154K
贸易债权人
USD 24.71M
应收帐款人
USD 6.83M


市值 更改 日
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Amgen USD 189.89B 13.64B 2026-03
Arca Biopharma USD 1.47B 537M 2025-12
Bayer EUR 38.69B 2.33B 2026-03
Biogen USD 26.9B 1.09B 2026-03
Brainstorm Cell Therapeutics USD 8M 3M 2025-09
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Capricor Therapeutics USD 1.66B 1.33B 2025-12
Cytokinetics USD 8.19B 420M 2026-03
Eisai JPY 1.42T 110.62B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Exelixis USD 10.89B 857M 2026-03
Geron USD 955M 112M 2026-03
Halozyme Therapeutics USD 7.66B 257M 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Ligand Pharmaceuticals USD 3.98B 241M 2026-03
Merck USD 297.1B 35.84B 2026-03
Novartis USD 307.76B 15.54B 2026-03
Pfizer USD 153.81B 12.24B 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03